Source: Annual Congress 2007 - Unravelling molecular mysteries of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sanzharovskaya, G. Chernogoryuk, N. Varvyanskaya, N. Jamkina, I. Pechorkina (Tomsk, Russian Federation). Possible mechanisms of protection of lung tissue in smokers without COPD. Eur Respir J 2007; 30: Suppl. 51, 924

Member's Comments

No comment yet.

Related content which might interest you: Possible role of airway mechanical stress in the genesis of COPD in smokers. The obesity model Source: Eur Respir J 2005; 26: Suppl. 49, 360s Year: 2005 Effect of smoking on lung functions in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 157s Year: 2005 Reduction of denitration-like activity in COPD lung tissue Source: Eur Respir J 2004; 24: Suppl. 48, 99s Year: 2004 Some pathogenetic mechanisms of inflammatory processes in smoking patients with COPD Source: Annual Congress 2007 - Smoking and the lung Year: 2007 Cigarette smoke alters the EZH2/DAB2IP expression in bronchial epithelial cells. A risk factor for lung cancer in COPD patients Source: International Congress 2016 – Studies in airway cell biology Year: 2016 Comparison of the neutrophils oxidative activity in patients with occupational lung diseases and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 119s Year: 2003 Morphological markers of resistance bronchial mucosa of smokers to the development of COPD Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Evidence for harm reduction in diseased smokers Source: Annual Congress 2007 - Targeting smokers by reduction: the "snus" connection revisited Year: 2007 Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers Source: Eur Respir J 2013; 41: 1058-1067 Year: 2013 COPD and lung cancer incidence in never smokers Source: International Congress 2019 – Asthma and COPD comorbidities Year: 2019 Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Airways and systemic inflammation and correlation to lung function in smokers and in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 651s Year: 2006 Differential regulation of inflammatory pathways in alveolar macrophages from COPD patients and smoking controls Source: Annual Congress 2007 - Novel mediators of cellular pathology Year: 2007 Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 Comparison of airway cellular and mediator profiles between tobacco smoke-induced COPD and biomass fuel exposure-induced COPD in an Indian population Source: Annual Congress 2011 - COPD: human studies Year: 2011 Analysis of the mucus properties in smokers with lung cancer or extra-pulmonary cancer and non smokers with pulmonary metastasis Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 COPD in patients with lung cancer and smoking Source: Eur Respir J 2005; 26: Suppl. 49, 519s Year: 2005 Patterns of lung function abnormalities in smokers as possible manifestation of "early" COPD phenotypes Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012